EUVIMEDEUVIMED entdecken
Crossref

In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections

Naveen Chaudhary, Harpreet Kaur, Vinay Modgil, Dharmender Singh, Ravi Kumar Maurya, Balvinder Mohan, Neelam Taneja

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.108005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Naveen Chaudhary und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address:…. Hauptthemen laut MEDLINE: Urinary Tract Infections, Anti-Bacterial Agents, Uropathogenic Escherichia coli, Phage Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic challenges caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria have necessitated the development of alternative treatment strategies. Phage-antibiotic synergy (PAS) has recently emerged to replace or possibly supplement antibiotics. We isolated the lytic phage NTNC80A from hospital sewage in Chandigarh, India, and it belongs to the class Caudoviricetes of viruses. We tested multiple strategies to investigate the synergistic effects of phage and antibiotic combinations against highly drug-resistant uropathogenic Escherichia coli isolates. The maximum synergistic effects (ΣFIC ≤0.5) were observed when phage NTNC80A was combined with ciprofloxacin simultaneously. Cell filamentation, characterised by elongated and interconnected cells, was observed at the sub-inhibitory ciprofloxacin doses (1/4,1/10 of MIC). Ciprofloxacin could accelerate cell lysis by stimulating filamentation, disrupting the peptidoglycan layer and enhancing susceptibility to phage enzymes. Phenotypic changes in phage and antibiotic-resistant mutants indicate that bacteria become susceptible to antibiotics or phages when their growth rate, metabolism, or resistance gene expression is altered. The simultaneous strategy outperformed the sequential strategy by enhancing synergistic effects and minimising the risk of resistance development. A significant reduction (p < 0.01-0.001) in bacterial loads in urine, bladder, and kidneys was observed in mice treated with a combination of phage (106 PFU) and sub-inhibitory concentrations of ciprofloxacin. The optimized phage-antibiotic combination reduced tissue bacterial burden and enhanced animal survival rate, indicating improved PAS therapeutic effects. These findings have significant implications for the future of UTI treatment strategies, particularly in the context of growing antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsAnti-Bacterial AgentsUropathogenic Escherichia coliPhage TherapyBacteriophagesEscherichia coli InfectionsAnimalsCiprofloxacinMiceMicrobial Sensitivity TestsDisease Models, AnimalDrug Resistance, Multiple, BacterialFemaleIndiaHumansSewageBacterial LoadKidney

Stichwörter der Autor:innen

Multidrug-resistancePhage therapySynergyUrinary tract infectionsUropathogenic Escherichia coli

Substanzen

Anti-Bacterial AgentsCiprofloxacinSewage

Autor:innen und Institutionen

  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Chaudharynaveen.999@gmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: sandhu.preet205@gmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: vnmodgil@gmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Dhruvjogi14@gmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: RKMAURYA9888@gmail.com.
  • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India. Electronic address: Balvindermohan2002@yahoo.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Chaudhary, N., Kaur, H., Modgil, V., Singh, D., Maurya, R. K., Mohan, B., & Taneja, N. (2025). In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.108005

Vancouver

Chaudhary N, Kaur H, Modgil V, Singh D, Maurya RK, Mohan B, et al. In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.108005

BibTeX
@article{Chaudhary2025,
  author = {Chaudhary, Naveen and Kaur, Harpreet and Modgil, Vinay and Singh, Dharmender and Maurya, Ravi Kumar and Mohan, Balvinder and Taneja, Neelam},
  title = {In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.108005}
}
Kostenlos starten →